Lilly's Cialis wins BPH extension in EU
This article was originally published in Scrip
Executive Summary
Lilly's erectile dysfunction drug Cialis (tadalafil) has won EU approval for treating the signs and symptoms of benign prostatic hyperplasia in adult males. It is the only drug in the EU to win approval for the two indications.